Vistagen Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2023
Total Assets: $21.1M
Liabilities Breakdown FY2023
Total Liabilities: $9.0M
Asset Breakdown
Total Assets: $21.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $16.6M | 78.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $507.0K | 2.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $3.9M | 18.7% |
Liabilities Breakdown
Total Liabilities: $9.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.5M | 27.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $6.5M | 72.5% |